Veradigm Inc. (NASDAQ:MDRX – Get Free Report) shares were up 6.8% on Monday . The company traded as high as $13.16 and last traded at $13.04. Approximately 514,772 shares were traded during mid-day trading, a decline of 50% from the average daily volume of 1,022,477 shares. The stock had previously closed at $12.21.
Analysts Set New Price Targets
A number of research analysts have weighed in on MDRX shares. Argus lowered shares of Veradigm from a “buy” rating to a “hold” rating in a research note on Thursday, July 6th. StockNews.com started coverage on shares of Veradigm in a report on Tuesday, September 12th. They set a “hold” rating for the company. Finally, Deutsche Bank Aktiengesellschaft cut their price target on shares of Veradigm from $21.00 to $18.00 in a report on Friday, June 30th. One analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $19.36.
Read Our Latest Stock Report on Veradigm
Veradigm Trading Up 7.7 %
Institutional Trading of Veradigm
Institutional investors have recently added to or reduced their stakes in the stock. Pinebridge Investments L.P. acquired a new stake in Veradigm in the 2nd quarter valued at approximately $26,000. Gladius Capital Management LP acquired a new position in shares of Veradigm in the first quarter worth $28,000. Quadrant Capital Group LLC grew its stake in shares of Veradigm by 200.5% in the second quarter. Quadrant Capital Group LLC now owns 2,263 shares of the software maker’s stock worth $29,000 after acquiring an additional 1,510 shares in the last quarter. Quarry LP acquired a new position in shares of Veradigm in the first quarter worth $37,000. Finally, Simplex Trading LLC acquired a new position in shares of Veradigm in the second quarter worth $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- Stock Sentiment Analysis: How it Works
- 2 Recession-Proof Intelligence Stocks to Defend Your Portfolio
- How to Invest in Artificial Intelligence
- 5 Reasons Mullen Automotive is About to Turn a Corner
- How to Use the MarketBeat Dividend Calculator
- Qualcomm and Apple Forge Ahead with New Modem Partnership
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.